665 related articles for article (PubMed ID: 28024700)
21. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
[TBL] [Abstract][Full Text] [Related]
22. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
23. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
[TBL] [Abstract][Full Text] [Related]
26. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
27. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
28. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
29. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
30. Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis.
Jin K; Zhang K; Zhou F; Dai J; Zhang P; Jiang G
Cancer Commun (Lond); 2018 Mar; 38(1):5. PubMed ID: 29764484
[TBL] [Abstract][Full Text] [Related]
31. Role of surgical resection for patients with limited disease-small cell lung cancer.
Takenaka T; Takenoyama M; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Lung Cancer; 2015 Apr; 88(1):52-6. PubMed ID: 25662387
[TBL] [Abstract][Full Text] [Related]
32. Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.
Yang CJ; Chan DY; Shah SA; Yerokun BA; Wang XF; D'Amico TA; Berry MF; Harpole DH
Ann Surg; 2018 Dec; 268(6):1105-1112. PubMed ID: 28475559
[TBL] [Abstract][Full Text] [Related]
33. Thoracic Surgery in Early-Stage Small Cell Lung Cancer.
Low M; Ben-Or S
Thorac Surg Clin; 2018 Feb; 28(1):9-14. PubMed ID: 29150041
[TBL] [Abstract][Full Text] [Related]
34. The progression of non-small cell lung cancer from diagnosis to surgery.
McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
[TBL] [Abstract][Full Text] [Related]
35. The number of lymph nodes examined is associated with survival outcomes and nodal upstaging in patients with stage I small cell lung cancer.
Chen Y; Zhang J; Jiang C; Zhang H; Fan P; Yu H; Zhang H; Fei K; Zhang P
Surg Oncol; 2021 Jun; 37():101513. PubMed ID: 33429326
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
37. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
38. Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.
Ahmed Z; Kujtan L; Kennedy KF; Davis JR; Subramanian J
Clin Lung Cancer; 2017 Sep; 18(5):e315-e325. PubMed ID: 28438510
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
